Studies have shown that the spatial distribution and differentiation state of tumor-associated B cells (such as FCRL4+ B cells) and CD8+ T cells in NPC may impact patient prognosis and the effectiveness of immunotherapy9-11. Here, FCRL4 is linked to neoplasm.